Use of direct-acting anticoagulants (DOACs) delays surgery and is associated with increased mortality in hip fracture patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Use of direct-acting anticoagulants (DOACs) delays surgery and is associated with increased mortality in hip fracture patients ; day:7 ; month:5 ; year:2024 ; pages:1-7
European journal of trauma and emergency surgery ; (7.5.2024), 1-7
- Urheber
-
Sundet, Mads
Sundin, Ulf
Godø, Aasmund
Sydnes, Kristian
Valland, Haldor
Sexton, Joseph
Martinsen, Mette
Paus, Maren
Rasmussen, Hans Schmidt
Lillegraven, Siri
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00068-024-02532-9
- URN
-
urn:nbn:de:101:1-2407180806426.215803625393
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sundet, Mads
- Sundin, Ulf
- Godø, Aasmund
- Sydnes, Kristian
- Valland, Haldor
- Sexton, Joseph
- Martinsen, Mette
- Paus, Maren
- Rasmussen, Hans Schmidt
- Lillegraven, Siri
- SpringerLink (Online service)
Ähnliche Objekte (12)
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report
Medication errors in relation to direct-acting oral anticoagulants: a qualitative study of pharmacists’ views and experiences
Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications
Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases
Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
Direct-acting antivirals and visceral leishmaniasis: a case report
Medications that interact with direct-acting oral anticoagulant exposure
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report
Medication errors in relation to direct-acting oral anticoagulants: a qualitative study of pharmacists’ views and experiences
Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications
Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases
Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
Direct-acting antivirals and visceral leishmaniasis: a case report
Medications that interact with direct-acting oral anticoagulant exposure
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report
Medication errors in relation to direct-acting oral anticoagulants: a qualitative study of pharmacists’ views and experiences
Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications
Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases
Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
Direct-acting antivirals and visceral leishmaniasis: a case report